HA
GMED icon

Homestead Advisers’s Globus Medical GMED Stock Holding History

Homestead Advisers’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Sell
40,725
-35,600
-47% -$3.03M 0.08% 79
2026
Q1 		$6.58M Hold
76,325
– – 0.18% 57
2025
Q4 		$6.66M Hold
76,325
– – 0.18% 55
2025
Q3 		$4.37M Hold
76,325
– – 0.1% 71
2025
Q2 		$4.5M Hold
76,325
– – 0.11% 72
2025
Q1 		$5.59M Buy
76,325
+10,100
+15% +$835K 0.14% 61
2024
Q4 		$5.48M Hold
66,225
– – 0.13% 67
2024
Q3 		$4.74M Hold
66,225
– – 0.11% 71
2024
Q2 		$4.54M Hold
66,225
– – 0.11% 68
2024
Q1 		$3.55M Hold
66,225
– – 0.08% 79
2023
Q4 		$3.53M Hold
66,225
– – 0.09% 84
2023
Q3 		$3.29M Buy
+66,225
New +$3.7M 0.09% 80

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Homestead Advisers's GMED Position: Q2 2026 in Review

Homestead Advisers reduced its Globus Medical (GMED) stake by 47% in Q2 2026, selling an estimated $3.03M and leaving 40,725 shares worth $3.22M. The position accounts for 0.08% of the portfolio, ranked #79.

Homestead Advisers first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.66M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Homestead Advisers held 40,725 shares of Globus Medical worth $3.22M as of Q2 2026.
  • Homestead Advisers sold 35,600 Globus Medical shares in Q2 2026, an estimated $3.03M.
  • Globus Medical made up 0.08% of Homestead Advisers's portfolio in Q2 2026, its #79 holding.
  • Homestead Advisers first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Homestead Advisers's Globus Medical position peaked at $6.66M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Homestead Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.